Investigators used data from 164 cognitively unimpaired individuals aged 60 to 91 years from 3 affiliated cohorts, including 98 from the Harvard Aging Brain Study, 33 from the Instrumental Activities of Daily Living Study, and 33 from the Subjective Cognitive Decline study. Approximately 21.9% were Aβ-positive and the rest were Aβ-negative.2
The study authors reported no significant differences in the performance between those who were Aβ-positive and -negative on any standard in-clinic cognitive tests, or on the first day of multi-day Boston Remote Assessment for Neurocognitive Health (BRANCH). The mean number of days for completion of BRANCH was 8.1 days, with a maximum of 14 days, with no differences in the groups. There were also no differences in completion time in the groups, with Aβ-positive individuals completing BRANCH in 12.23 minutes, and Aβ-negative individuals completing it in 12.11 minutes, according to the results.2 There were 3 tasks, including the Digit Sign Test (6 street signs paired with digits and assessment on the correct digit-sign pairing), the Groceries Test (prices paired with a picture of a grocery item for individuals to recall), and FNAME (a series of faces and names for individuals to choose the correct name via multiple choice).1
3 Key Takeaways
- The study suggests that a smartphone-based cognitive test, conducted over several days, can be a valuable tool for identifying early changes in β-amyloid associated with Alzheimer's disease (AD).
- By assessing learning over a period of several days, researchers observed diminished 7-day learning curves in individuals with elevated amyloid levels, indicating potential AD-related memory declines.
- The investigators plan to use the BRANCH paradigm in a clinical trial to identify individuals eligible for AD secondary prevention trials.
The results showed that those who were Aβ-positive had diminished 7-day learning curves after 4 days of testing compared to Aβ-negative individuals. Further, the decline in learning curves were also associated with greater annual PACC-5 decline, according to the results.2
The study authors concluded that learning over repeated evaluation could demonstrate AD-related memory declines. They added that this would show the decline in preclinical AD, which is not easily observed during a single time point assessment.2
The pattern for the diminished learning curve, which was associated with elevated amyloid, was consistent across 3 memory tasks and was strongest for digit signs and groceries prices.2
The investigators plan to conduct a clinical trial using the BRANCH paradigm and help identify those eligible for AD secondary prevention trials.1
References
- Mass General Brigham study finds daily learning test can detect Alzheimer’s disease-related changes in memory among cognitively normal older adults. News release. EurekAlert. December 26, 2023. Accessed January 2, 2024. https://www.eurekalert.org/news-releases/1029883
- Papp KV, Jutten RJ, Soberanes D, Weizenbaum E, et al. Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital Testing. Ann Neurol. 2023. doi:10.1002/ana.26833